← Back to Search

Integrated Weight and Pain Management for Obesity and Chronic Pain (STOP Trial)

N/A
Waitlist Available
Led By Elizabeth A Janke, PhD
Research Sponsored by University of the Sciences in Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chronic, non-cancer pain (pain at a level ≥ 4 on a scale of 0-10 on a majority of the days for 6 months or more prior to study participation)
Be older than 18 years old
Must not have
Have an unstable medical or psychiatric condition
Non-fluent in spoken or written English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 12 months
Awards & highlights

Summary

This trial is testing whether an integrated approach to treating obesity and pain results in better outcomes than treating each condition separately. All participants will receive some form of treatment, with the type of treatment they receive determined by chance.

Who is the study for?
The STOP Trial is for adults over 18 with a BMI of 25 or higher who have chronic, non-cancer pain (pain level ≥4 for most days in the past 6 months). It's not suitable for those with unstable medical/psychiatric conditions, substance abuse issues, bulimia, non-English speakers, recent/current pregnancy, significant cognitive impairments, or if they're already in similar programs.
What is being tested?
This trial tests whether integrated behavioral treatments can help people who are overweight and suffer from chronic pain. Participants will be randomly assigned to one of three groups: standard weight loss treatment; standard pain management treatment; or an integrated approach targeting both weight loss and pain.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, side effects may include discomfort from lifestyle changes such as dieting and exercise. Psychological distress could also occur due to addressing chronic pain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had chronic pain at a level of 4 or higher for over 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any unstable medical or mental health conditions.
Select...
I am not fluent in English.
Select...
I have significant thinking or movement problems that prevent me from participating in treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain intensity from baseline to 12 months
Change in weight from baseline to 12-months
Secondary study objectives
Change in pain disability from baseline to 12 months
Change in quality of life from baseline to 12 months

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: STOP InterventionExperimental Treatment1 Intervention
The STOP treatment includes content designed to simultaneously and explicitly target both chronic pain and obesity. Treatment components are drawn from evidence-based interventions for chronic pain and obesity, separately.
Group II: Standard Care Pain (SCP)Active Control1 Intervention
The chronic pain intervention is focused around reconceptualization of pain, decreasing catastrophizing, and increasing self-efficacy for pain. This content has been chosen because of its demonstrated effectiveness and importance in non-pharmacological interventions to improve pain management.
Group III: Standard Care Weight (SCW)Active Control1 Intervention
The weight loss intervention includes content focused around nutrition and eating habits, stimulus control and behavioral change, and physical activity. This content has been chosen because of its demonstrated effectiveness and importance in behavioral interventions to reduce weight.

Find a Location

Who is running the clinical trial?

University of the Sciences in PhiladelphiaLead Sponsor
13 Previous Clinical Trials
789 Total Patients Enrolled
Elizabeth A Janke, PhDPrincipal InvestigatorUniversity of the Sciences in Philadelphia

Media Library

Chronic Pain Self-Management Clinical Trial Eligibility Overview. Trial Name: NCT02100995 — N/A
Obesity Research Study Groups: Standard Care Pain (SCP), STOP Intervention, Standard Care Weight (SCW)
Obesity Clinical Trial 2023: Chronic Pain Self-Management Highlights & Side Effects. Trial Name: NCT02100995 — N/A
Chronic Pain Self-Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT02100995 — N/A
Obesity Patient Testimony for trial: Trial Name: NCT02100995 — N/A
~233 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top